The Medical Device Business Journal — Medical Device News & Articles | MassDevice
BiOM has raised $6 million through a debt and equity financing, according to regulatory filing with the Federal Securities and Exchange Commission.
The Bedford, Mass.-based BiOM (formerly known as iWalk) listed 18 investors in the Dec. 23rd filing, including an unnamed "non-U.S. purchaser." which invested a total of $1,079,160 into the bionics prosthetics maker. The company is looking to raise up to $10 million in this round.
BiOM has named Dr. Charles Carignan as its next CEO, replacing Tim McCarthy, who left the company this past spring.
Carignan is a 20-year medtech veteran who has held several key positions in the medical device industry, including most recently at NinePoint Medical, where he was the founder and CEO.
A version of this story was originally posted on BetaBoston.com
BEDFORD, Mass.–(BUSINESS WIRE)–iWalk,
the bionics company advancing technology to restore natural movement for
lower-limb amputees, today announced the publication of positive
findings from Proceedings
Prosthetic foot developer iWalk drummed up $15 million in venture funding, according to The Boston Globe.
The Cambridge, Mass.-based MIT spin-out is commercializing a robotic prosthesis called PowerFoot designed to sense the position of its wearer’s ankle and react to different walking conditions.
